online game philippines
Things White Celebs Can Get Away With That Black Celebs Can't, 15 Shoes Sneakerheads Loved This Year, Christmas Songs Black People Should Know, Tiger Woods' Son Achieves Viral Accomplishment And MoreChina-Linked Hackers Breached 8 US Telecom Companies, White House Says
Barcelona grabs last quarterfinal spot in Women's Champions League with 3-0 win in StockholmPARADIGM CAPITAL MANAGEMENT LIVE WITH INDATA
Three former Obama staffers are selling “ANTIFA” outfits for babies in an online store. The leftist political media group known as Crooked Media, which the former Democrat president’s ex-staffers, Jon Favreau, Jon Lovett, and Tommy Vietor, who are also called the “Obama Bros,” co-founded in 2017, is selling the items and others, Fox News reported Thursday: The “ANTIFA” baby onesies sell for $18.00 on the Crooked Store website. Click here to see the merchandise. “Conservatives already think we’re churning out mini Antifa warriors, so maybe we should start,” the description reads. The three men also co-host the popular “Pod Save America” political podcast. The Fox report continued: “ANTIFA” is a common term used to refer to far-left “anti-fascists” who were at the forefront of the George Floyd protests during the summer of 2020. Many of those protests devolved into violent riots, even resulting in the deaths of dozens of people and billions of dollars in property damage because of the unrest. Following that summer, ANTIFA continued to deploy violent tactics. A spokesperson for Crooked Media told Fox News Digital that the clothes it has listed on its website “are not a joke,” but also quipped that “all toddlers are antifa until their souls are broken by capitalism.” The online store also offers onesies with the words “BIRTH CONTROL” and “WOKE MOB” printed on the front. In his opinion piece for Fox regarding the leftist merchandise, Shapiro Professor of Public Interest Law at George Washington University Jonathan Turley wrote : With tensions rising after the election, the embrace of organizations like Antifa will only fuel calls for violent action. Liberal figures like ex-Washington Post reporter Taylor Lorenz have even conveyed support for the assassination of UnitedHealthcare CEO Brian Thompson in Manhattan. It is not the time to go full naughty list to celebrate a group that regularly beats reporters and others with opposing viewpoints. While this may appeal to your own special smash-mouth Santa, tis not the season for political violence. In 2019, the Heritage Foundation called Antifa a “far-left revolutionary movement” that had organized mass violence in major cities across the United States. Click here to read more articles about Antifa.FOBI AI Inc. Announces Proposed Private Placement and BCSC Order
The FBI is warning iPhone and Android users against texting each other without encryption due to a recent Chinese cyberattack. On Wednesday, deputy national security adviser Anne Neuberger announced that at least eight U.S. telecom companies had been breached by a Chinese hacking operation known as "Salt Typhoon." The operation accessed private text messages and phone conversations involving an undisclosed number of Americans. The hackers are believed to have successfully intercepted the communications of senior government officials and high-profile political figures. However, Neuberger said the government did not think "any classified communications" had been accessed. In response to the attack, the FBI and Cybersecurity and Infrastructure Security Agency (CISA) released guidance aimed at identifying the hackers and preventing future cyberattacks. Since communications between iPhone and Android users are not encrypted by default, agency officials urged Americans to stop sending texts between the two operating systems or use third-party apps with end-to-end encryption. Why Aren't Text Messages End-to-End Encrypted? SMS messaging first emerged in the early 1990s, when there were far fewer concerns surrounding text message security. At this point, altering SMS to include end-to-end encryption would likely be impractical or impossible. However, modern text messages often do not use SMS and are transmitted using other systems, such as Apple 's iMessage and Google Messages. Are iMessage, WhatsApp, Signal and Google Messages Encrypted? Text messages between iPhone users and between Android users do include end-to-end encryption by default. However, messages transmitted between the two systems are not encrypted and could be vulnerable. WhatsApp and Signal both offer end-to-end encryption. NBC News reported on Wednesday that CISA official Jeff Greene and a senior FBI official both urged Americans to use an encrypted app instead of communicating between iPhone and Android devices. "Encryption is your friend, whether it's on text messaging or if you have the capacity to use encrypted voice communication," said Greene. "Even if the adversary is able to intercept the data, if it is encrypted, it will make it impossible." How Can You Tell If Someone Has Encrypted Messages? As messages with end-to-end encryption can only be read using a type of "key" that is only available to the sender and receipt, the content of the messages remains inaccessible when hacked by a third party. Encrypted messages between iPhone users appear in blue. On Android devices, a lock icon under a message or an indication that the message is being sent using RCS (Rich Communication Services) protocol denotes encryption. What Is Salt Typhoon? "Salt Typhoon" is a nickname given to the Chinese hacking operation by Microsoft . The group has also been referred to using the nicknames "FamousSparrow" and "Ghost Emperor." While U.S. intelligence officials have tied the group to the Chinese government, Liu Pengyu, the spokesperson for the Chinese embassy in Washington, denied involvement earlier this week while insisting that "the U.S. needs to stop its own cyberattacks against other countries and refrain from using cyber security to smear and slander China." Update 12/5/24, 6:45 p.m. ET: This article was updated with additional information.
GOP Senator Says Trump Should ‘Immediately Fire’ DOJ Staff Involved in Cases Against Him
Philadelphia (8-2) at Los Angeles Rams (5-5) Sunday, 8:20 p.m. EST, NBC/Peacock BetMGM NFL odds: Eagles by 3. Against the spread: Eagles 6-4; Rams 4-6. Series record: Eagles lead 23-20-1. Last meeting: Eagles beat Rams 23-14 in Inglewood, Calif. on Oct. 8, 2023. Last week: Eagles beat Washington 26-18; Rams beat New England 28-22. Eagles offense: overall (5), rush (1), pass (22), scoring (7). Eagles defense: overall (1), rush (7), pass (2), scoring (6). Rams offense: overall (17), rush (26), pass (T-7), scoring (21). Rams defense: overall (23), rush (18), pass (22), scoring (22). Turnover differential: Eagles plus-2; Rams plus-4. Eagles player to watch RB Saquon Barkley. Barkley combined for 198 scrimmage yards and two scores, rushing 26 times for 146 yards (5.6 average) while adding two receptions for 52 yards against Washington. With 1,137 rushing yards through 10 games, Barkley only trails Baltimore’s Derrick Henry for the NFL lead. He had his sixth 100-plus yard rushing game this season, which is the most in the NFL. Rams player to watch S Kam Kinchens. The rookie third-round pick from Miami had eight tackles, one tackle for loss, an interception and a forced fumble against the Patriots as he continues to come on strong. Kinchens has three picks in the past three games. Key matchup Eagles QB Jalen Hurts vs. Rams’ defensive line. Hurts shredded Los Angeles for 303 yards passing and 72 yards rushing last season despite the presence of superstar DT Aaron Donald. After Donald retired, the Rams turned to a committee approach to get after the passer, and it has worked with rookie OLB Jared Verse and DT Braden Fiske fitting in well next to second-year OLB Byron Young and DT Kobie Turner. But they can only unleash their excellent pass rush skills by limiting Philadelphia on early downs. Hurts has been at his dual-threat best over the past five games, accounting for 15 total touchdowns (six passing, nine rushing) against two turnovers. Key injuries Eagles defensive end Bryce Huff had surgery on his left wrist on Thursday, a move that could allow him to return toward the end of the season. ... WR DeVonta Smith (hamstring) and DT Milton Williams (foot) each missed practice this week. ... Rams RT Rob Havenstein (ankle) looks to be trending toward a return this week. Havenstein sat out the previous two games because of the ailment. Series notes The Eagles have won all three games in Los Angeles since the Rams moved back in 2016. ... Overall, Philadelphia has won seven of the past eight. The only setback came in Week 2 of the 2020 pandemic season. Stats and stuff Barkley has passed 100-plus scrimmage yards in eight of 10 games. That is tied with LeSean McCoy (2011) and Brian Westbrook (2007) for the most by an Eagle through 10 games. His 198 yards were his second most as an Eagle (199 in Week 9). ... The Eagles have allowed two passing touchdowns during their winning streak. Only one opponent has topped 200 passing yards against them in this stretch, with Cincinnati throwing for 222 in Week 8. ... Hurts leads all NFL quarterbacks with 11 touchdown runs and is second only to Henry's 13 scores for the Ravens. ... WR A.J. Brown leads the league in receptions of 30 yards or longer. He is averaging 18.7 yards per catch, the best mark of any player with at least 30 grabs. ... Even before he hurt his wrist, Huff struggled in his first season in Philadelphia with just 2 1/2 sacks and four quarterback hits. His snap count has dipped since he was injured ahead of a game earlier this month against Jacksonville. Huff had 17 1/2 sacks in four seasons with the Jets before he signed a three-year, $51 million free-agent deal with the Eagles. ... Philadelphia has run for at least 150 yards and two touchdowns in five straight games, something it hadn't accomplished since 1949. ... Rams WR Puka Nacua caught his first touchdown of the season in New England. He has at least seven receptions and 98 yards in three of his past four games, with only a second-quarter ejection in Seattle having limited Nacua since he returned from a knee injury. ... WR Cooper Kupp has 614 receptions through his first 98 games, which is fourth most in NFL history through 100 games. Julio Jones (619) is third. ... RB Kyren Williams averaged a season-high 5.7 yards per carry, finishing with 86 yards on 15 attempts versus the Patriots. ... Verse has 11 tackles for loss and 4 1/2 sacks through his first 10 games. Verse is pressuring the quarterback on 20.2% of pass rush snaps, which ranks second in the league overall. ... The Rams were 2 of 8 (25%) on third down against New England, their third straight game converting 25% or worse. ... QB Matthew Stafford has not been sacked in each of Los Angeles’ past three wins. Fantasy tip Don’t be discouraged using Stafford, Kupp and Nacua against Philadelphia's pass defense. All three put up solid fantasy numbers in last season’s meeting, even as the Eagles sat on the ball for nearly 38 minutes. Stafford had 222 yards and two scores, finding Kupp eight times for 118 yards and Nacua seven times for 71 yards and a touchdown, so they'll find ways to produce. AP NFL: https://apnews.com/hub/NFLRobinhood's chief legal officer sells $477,793 in stock
Implements INDATA SaaS on a Front-to-Back Office Basis delivered via iPM Private Cloud GREENWICH, Conn. , Dec. 12, 2024 /PRNewswire/ -- INDATA , a leading industry provider of cloud-native, SaaS-based solutions for buyside firms, today announced that Paradigm Capital Management (PCM) is live with INDATA's Software-as-a-Service for Front, Middle and Back Office . With a three-decade history of small-cap investing, Paradigm Capital Management, based in Albany, NY employs a disciplined, bottom-up approach with an emphasis on fundamental analysis and extensive management contact. Paradigm manages $1.8 billion in AUM and offers a range of products including institutional separately managed accounts, proprietary mutual funds, and private wealth via hedge funds and LP's. Paradigm is using the INDATA system for a range of functions including trade order management (OMS), Portfolio Accounting , Performance and Reporting, including managed services for streamlined reconciliation. "We are very pleased to have Paradigm Capital Management as a client. We look forward to partnering with Paradigm on their ongoing needs," commented David Csiki , President of INDATA. About INDATA ® INDATA is a leading specialized provider of SaaS (Software-as-a-Service), technology and managed outsourcing services for buyside firms, including trade order management (OMS), portfolio management, compliance, portfolio accounting and front-to-back office. INDATA iPM Portfolio Architect AITM is the industry's first portfolio construction, modeling, rebalancing and reporting tool based on AI, and Machine Learning. INDATA's iPM – Intelligent Portfolio Management® technology platform allows end users to efficiently collaborate in real-time across the enterprise and contains the best of class functionality demanded by sophisticated institutional investors, wealth managers, and hedge funds. The company's mission is to provide clients with cutting edge technology products and services to increase trading and operational efficiency while reducing risk and administrative overhead. INDATA provides software and services to a variety of buyside clients including asset managers, registered investment advisors, banks and wealth management firms, pension funds and hedge funds. Assets under management range from under $1 billion to more than $100 billion across a variety of asset classes globally. For more information, visit www.indataipm.com Media Contact: David Csiki , dave@indataipm.com View original content: https://www.prnewswire.com/news-releases/paradigm-capital-management-live-with-indata-302330839.html SOURCE INDATA
Yes, it’s safe to use Login.gov to access Social Security accounts online
The hematology market is experiencing significant growth driven by the increasing prevalence of blood-related disorders, advancements in research and product development, and the rising number of elderly individuals vulnerable to these conditions. Additionally, the growing adoption and awareness of minimally invasive procedures have further boosted the demand for hematology devices, supporting the market's expansion during the forecast period from 2024 to 2030. LAS VEGAS , Dec. 12, 2024 /PRNewswire/ -- DelveInsight's Hematology Market Insights report provides the current and forecast market analysis, individual leading hematology companies' market shares, challenges, hematology market drivers, barriers, trends, and key market hematology companies in the market. Key Takeaways from the Hematology Market Report As per DelveInsight estimates, North America is anticipated to dominate the global hematology market during the forecast period. In the type segment of the hematology market, coagulation analyzers are estimated to hold a higher share of the hematology market during the forecast period (2024-2030). Notable hematology companies such as Sysmex Corporation, Danaher, Nihon Kohden Corporation, Siemens Healthcare GmbH, Abbott, Boule Diagnostics, Bio-Rad Laboratories, Inc., Biosystems S.A., Diatron, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Erba Mannheim , Ortho Clinical Diagnostics, Abaxis, Heska Corporation, F. Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, and several others, are currently operating in the hematology market. In December 2024 , Immune-Onc Therapeutics, Inc. shared updated results from its Phase 1b expansion cohort study of IO-202. This first-in-class anti-LILRB4 antibody was evaluated in combination with azacitidine (AZA) for the treatment of chronic myelomonocytic leukemia (CMML). The latest findings were presented during an oral session at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego, California . In December 2024 , BeiGene, Ltd. showcased new clinical data at the 66th American Society of Hematology (ASH) Annual Meeting, highlighting its leadership in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) through the ongoing clinical success of BRUKINSA (zanubrutinib) and notable progress in its pipeline developments. In December 2024 , Nurix Therapeutics, Inc. shared new encouraging clinical data from patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were treated in the Phase 1a/ 1b clinical trial of its Bruton's tyrosine kinase (BTK) degrader, NX-5948. In December 2024 , Bristol Myers Squibb shared results from 18 presentations that underscore its leadership in cell therapy. The data highlighted the effectiveness, durability, and safety of existing therapies for blood cancers, while also showcasing the promise of its pipeline for future applications, including autoimmune diseases. These findings, which span a wide range of potential targets across various disease areas, were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California . In December 2024 , Taiho Oncology, Inc. shared the findings of two studies on oral treatments for patients with myelodysplastic syndromes (MDS) and MDS/myeloproliferative neoplasm (MPN) at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH), held from December 7-10, 2024 , in San Diego . To read more about the latest highlights related to the hematology market, get a snapshot of the key highlights entailed in the Global Hematology Market Report Hematology Overview Hematology is a specialized branch of medicine that focuses on the study, diagnosis, treatment, and prevention of blood-related disorders and diseases. It encompasses a wide range of conditions, including anemia, clotting disorders, leukemia, lymphoma, and myeloma. Hematologists work to understand the intricate components of blood, such as red blood cells, white blood cells, platelets, hemoglobin, and plasma, as well as the organs responsible for blood production, like the bone marrow, lymph nodes, and spleen. The field is integral to understanding the body's immune system, oxygen transport, and coagulation processes, as these functions are closely tied to overall health. Advances in hematology, such as molecular diagnostics, targeted therapies, and bone marrow transplantation, have revolutionized the way hematologic diseases are managed. In recent years, hematology has witnessed significant breakthroughs, particularly in understanding the genetic and molecular basis of blood disorders. Cutting-edge therapies, including immunotherapy and gene editing technologies like CRISPR, are providing hope for patients with previously untreatable conditions. For instance, the development of antibody-drug conjugates and CAR-T cell therapies has improved outcomes for individuals with certain blood cancers. In addition, research into hematopoietic stem cell transplantation continues to expand, offering curative potential for diseases such as sickle cell anemia and severe aplastic anemia. As the field evolves, it not only enhances our understanding of blood and its disorders but also contributes to broader medical advancements in oncology, immunology, and regenerative medicine. Hematology Market Insights North America is anticipated to hold the largest share of the global hematology market. This dominance can be attributed to factors such as the growing prevalence of chronic blood disorders, a rising incidence of these conditions among the aging population, and advancements in product offerings, which collectively support the expansion of the hematology market in the region. The increasing number of blood disease cases underscores the demand for hematology in treatment, driving market growth in North America . Additionally, a strong focus on product innovation and the proactive efforts of device manufacturers to penetrate local markets through strategic partnerships contribute further to regional market development. These collaborations are likely to stimulate product demand. Consequently, a combination of factors—such as a large patient base, favorable reimbursement policies, and the introduction of new products—is expected to propel the growth of the North American hematology market during the forecast period. To know more about why North America is leading the market growth in the hematology market, get a snapshot of the Hematology Market Outlook Hematology Market Dynamics The hematology market has undergone significant evolution in recent years, driven by advancements in biotechnology, growing demand for precision medicine, and the increasing prevalence of hematologic disorders such as leukemia, lymphoma, and multiple myeloma. Hematology encompasses both diagnostics and therapeutics, making it a critical domain within healthcare. The rise in patient awareness and improvements in early detection technologies are boosting the diagnostic segment, while innovative treatments, including monoclonal antibodies, CAR-T therapies, and bispecific antibodies, dominate the therapeutic landscape. Additionally, the integration of genetic profiling into routine care has enabled tailored therapies, further propelling the market. One of the key dynamics shaping the hematology market is the shift towards targeted therapies , particularly for rare blood disorders and cancers. Traditional chemotherapies are being replaced or supplemented by highly specific treatments that minimize side effects and improve efficacy. In diseases like hemophilia, the adoption of gene therapies and recombinant products has been transformative. Similarly, the field of immuno-oncology is gaining traction, with treatments like immune checkpoint inhibitors and antibody-drug conjugates showing promise in hematologic malignancies. On the diagnostic side, the emergence of high-throughput technologies such as next-generation sequencing (NGS) and liquid biopsy has revolutionized disease detection and monitoring. These technologies allow for earlier diagnosis, better prognosis determination, and the ability to track disease progression or recurrence with higher accuracy. The growing demand for point-of-care (POC) diagnostics , especially in resource-limited settings, is further expanding the reach of hematology diagnostics to underserved populations. Despite these advances, the market faces several challenges, including high costs associated with novel therapies and diagnostics, regulatory hurdles, and access disparities , particularly in low- and middle-income countries. The complexity of personalized treatments also necessitates robust healthcare infrastructure, which is not uniformly available across regions. Furthermore, the market is highly competitive , with pharmaceutical and biotech companies vying for leadership in niche indications, leading to intense research and development (R&D) activities. Looking forward, the hematology market is expected to continue its growth trajectory, fueled by the integration of artificial intelligence (AI) and machine learning into research, diagnosis, and treatment development. These technologies have the potential to optimize patient outcomes and streamline healthcare delivery. Collaborations between academia, biotech firms, and pharmaceutical giants are likely to accelerate innovation, while regulatory frameworks are anticipated to evolve to better accommodate cutting-edge therapies. As the field advances, the hematology market remains a cornerstone of modern medicine, addressing unmet needs and improving quality of life for patients globally. Get a sneak peek at the hematology market dynamics @ Hematology Market Dynamics Analysis Hematology Market Assessment Hematology Market Segmentation Hematology Market Segmentation By Type: Instruments (Hematology Analyzers, Hematology Cell Counters, Flow Cytometers, Coagulation Analyzers, Others), Kits and Reagents Hematology Market Segmentation By Application: Cardiovascular Diseases, Auto-Immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others Hematology Market Segmentation By Modality: Clinical Laboratory Devices, Point of Care Devices Hematology Market Segmentation By End User: Hospitals & Clinics, Diagnostic Laboratories, Others Hematology Market Segmentation By Geography : North America , Europe , Asia-Pacific , and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the hematology market are set to emerge as the trendsetter explore @ Hematology Companies Table of Contents Interested in knowing the hematology market by 2030? Click to get a snapshot of the Hematology Market Trends Related Reports Hematological Cancer Therapeutics Market Hematological Cancer Therapeutics Market Insight, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key hematological cancer therapeutics companies, including Pfizer Inc., F. Hoffmann-LA Roche Ltd, Sanofi SA, Bristol-Myers Squibb Company, AbbVie Inc, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Takeda Pharmaceutical Co. Ltd, Johnson & Johnson, Incyte Corporation, AstraZeneca PLC, Celldex Therapeutics Inc., Kite Pharma (Gilead Sciences), Atara Biotherapeutics, Celgene Corporation, Astellas, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, among others. Coagulation Analyzers Market Coagulation Analyzers Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key coagulation analyzers companies, including Abbott Laboratories Inc., Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Nihon Kohden Corporation, Maccura Biotechnology Co., Ltd., Bio-Group Medical System, Genrui Biotech Inc., A&T Corporation, Stago Group, Beijing Succeeder Technology Inc., Helena Laboratories Corporation, BPC BioSed S.R.L., Meril Life Sciences Pvt. Ltd., SCLAVO Diagnostics International, Erba Group, ACON Laboratories, Inc., Haemonetics Corporation , among others. Flow Cytometry Market Flow Cytometry Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key flow cytometry companies, including Thermo Fisher Scientific Inc., BD, Stratedigm, Inc, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Corporation, Agilent Technologies, Inc., Sony Biotechnology Inc., bioMérieux SA, Enzo Life Sciences, Inc., Union Biometrica, Inc., Cytek Biosciences, Sartorius AG, Beckman Coulter , Inc., Apogee Flow Systems Ltd., Molecular Instruments, Inc., Integrated DNA Technologies, Inc., New England Biolabs (NEB), ACROBiosystems , among others. Coagulation Factor Deficiency Market Coagulation Factor Deficiency Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key coagulation factor deficiency companies, including Novo Nordisk, Spark Therapeutics, Sanofi (Genzyme), Alnylam Pharmaceuticals, Pfizer, Biotest AG, Centessa Pharmaceuticals (Apcintex), Staidson Biopharma Inc., Ultragenyx Pharmaceutical, Bayer , among others. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact Us Shruti Thakur [email protected] +14699457679 https://www.delveinsight.com/medical-devices Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg SOURCE DelveInsight Business Research, LLP
Middle East latest: Israeli strikes in Gaza kill more than 50 people, including kidsNoneOTTAWA — Brampton Mayor Patrick Brown said foreign interference did not tip the scales in the Conservative party’s last leadership race that installed Pierre Poilievre at the helm. But he offered up Thursday that he changed some of the language he was using after getting pushback from an Indian diplomat that some of his comments could sound like he was endorsing ideas of Sikh nationalism. Brown, who was a candidate for the leadership in 2022, was summoned to a House of Commons committee Thursday to answer questions on the 2022 race after a report from a committee on national security referred to allegations of Indian interference in an unspecified Conservative leadership campaign. “I don’t believe foreign intervention affected the final outcome of the Conservative leadership race,” Brown told the House of Commons public safety and national security committee Thursday. A CBC/Radio-Canada article this week quoted several confidential sources from Brown’s campaign alleging that representatives from India’s consulate interfered to undermine his leadership bid. On Monday, Brown posted on social media about the committee’s summons to say that he had no new evidence to add, and that the public inquiry on foreign interference was the proper venue to evaluate the allegations. Brown insisted to the committee Thursday that no members of the Indian government reached out to him or his campaign workers during his leadership bid, saying the relationship was “already very strained” at that point. The CBC News story also contained allegations that his national campaign co-chair Conservative MP Michelle Rempel Garner was pressured to withdraw her support for Brown — something she denied. When NDP MP Alistair MacGregor quizzed him on the news report, asking why she left the campaign, Brown said she left seeking to launch her own leadership bid to replace UCP leader Jason Kenney in Alberta — not from pressure from India. “At no time when we talked about her departing the campaign did she ever say it was over pressure from the consul general,” he said. He said the article likely referred to a conference call more than a month before she left, after the consul general raised concerns with Rempel Garner about Brown using the words “Sikh nation.” “The consul general had expressed directly to (Rempel Garner) that, obviously that was something they didn’t agree with, that it could be viewed in nationalistic terms towards the Sikh community,” he said. That led him to change the language he was employing to a Punjabi term that he said meant the same thing. Liberal MP Jennifer O’Connell asked if that’s “an appropriate election activity by a foreign government,” charging it was a clear instance of foreign interference. Brown replied that Indian officials “have been more robust in their opinions than some of us would be comfortable with.” A bombshell report by the National Security and Intelligence Committee of Parliamentarians into foreign interference released last spring referred to “India’s alleged interference in a Conservative Party of Canada leadership race.” Brown said he was not under any kind of non-disclosure agreement with the Conservative Party that prevents him from speaking publicly about what happened during the race. He said he believes it’s important to guard against foreign meddling in democracy but that he does not want to get drawn into partisan debates on Parliament Hill. Brown was not included as a witness in the public inquiry into foreign interference, which wrapped up hearings earlier this fall with a final report due in the new year. He was disqualified from the party’s 2022 leadership race due to allegations related to financing rules in the Canada Elections Act. This report by The Canadian Press was first published Dec. 5, 2024. Kyle Duggan, The Canadian Press
None
- Previous: online game of the generals
- Next: online game uno
